Aktie BIBCL6 BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Bharat Immunologicals & Biologicals Corporation Limited

Aktien

BIBCL6

INE994B01014

BIBCL6

Markt geschlossen - Bombay S.E.
Andere Börsenplätze
 12:16:01 13.05.2024 		% 5 Tage % 1. Jan.
30,05 INR +2,42 % Intraday Chart für Bharat Immunologicals & Biologicals Corporation Limited -1,02 % -14,99 %
2023 Bharat Immunologicals & Biologicals Corporation Limited meldet Gewinnergebnisse für das zweite Quartal und die sechs Monate bis zum 30. September 2023 CI
2023 Bharat Immunologicals & Biologicals Corporation Limited meldet die Ergebnisse für das erste Quartal bis zum 30. Juni 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Bharat Immunologicals & Biologicals Corporation Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
Bharat Immunologicals & Biologicals Corporation Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
Bharat Immunologicals & Biologicals Corporation Limited Reports Earnings Results for the Full Year Ended March 31, 2023
Bharat Immunologicals & Biologicals Corporation Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
Bharat Immunologicals & Biologicals Corporation Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
Bharat Immunologicals & Biologicals Corporation Limited Reports Earnings Results for the First Quarter Ended June 30, 2022
EU countries agree to admit travellers vaccinated with WHO-approved shots
Bharat Immunologicals & Biologicals Corporation Limited Reports Earnings Results for the Third Quarter Ended December 31, 2021
EU proposes booster jabs for 2022 travel, opens to WHO vaccines
Bharat Immunologicals & Biologicals Corporation Limited Reports Earnings Results for the Second Quarter Ended September 30, 2021
Bharat Immunologicals & Biologicals Corporation Limited Reports Earnings Results for the First Quarter Ended June 30, 2021
Bharat Immunologicals & Biologicals Corporation Limited Reports Earnings Results for the Full Year Ended March 31, 2021
Bharat Immunologicals & Biologicals : to Receive Indian Government Funding for COVID Vaccine Production
Bharat Immunologicals & Biologicals Corporation Limited Reports Earnings Results for the Third Quarter Ended December 31, 2020
Bharat Immunologicals & Biologicals Corporation Limited Reports Earnings Results for the Second Quarter Ended September 30, 2020
Bharat Immunologicals & Biologicals Corporation Limited Reports Earnings Results for the Full Year Ended March 31, 2020
Bharat Immunologicals & Biologicals Corporation Limited Reports Earnings Results for the Third Quarter Ended December 31, 2019
Bharat Immunologicals & Biologicals Corp. Ltd. Reports Earnings Results for the Second Quarter Ended September 30, 2019
Bharat Immunologicals & Biologicals Corporation Limited Reports Earnings Results for the First Quarter Ended June 30, 2019
Bharat Immunologicals & Biologicals Corporation Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2019
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. BIBCL6 Aktie
  4. Nachrichten Bharat Immunologicals & Biologicals Corporation Limited
  5. Andere Sprachen